Premium
MicroRNA‐378 regulates epithelial–mesenchymal transition and metastasis of melanoma by inhibiting FOXN3 expression through the Wnt/β‐catenin pathway
Author(s) -
Sun Mengyao,
Ma Xiaona,
Tu Chen,
Wang Xiaopeng,
Qu Jianqiang,
Wang Shuang,
Xiao Shengxiang
Publication year - 2019
Publication title -
cell biology international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.932
H-Index - 77
eISSN - 1095-8355
pISSN - 1065-6995
DOI - 10.1002/cbin.11027
Subject(s) - melanoma , microrna , wnt signaling pathway , cancer research , epithelial–mesenchymal transition , metastasis , catenin , biology , in vivo , cancer , signal transduction , gene , microbiology and biotechnology , genetics
MicroRNAs (miRNAs) participate in the development and progression of melanoma. However, while dysregulation of microRNA‐378 (miR‐378) has been seen in various cancer types, its clinical importance and function in melanoma are poorly elucidated. In this work, miR‐378 expression in melanoma and in adjacent non‐cancerous tissue was evaluated with a quantitative real‐time polymerase chain reaction. A series of assays (wound healing, Transwell, and nude mouse subcutaneous tumor model) were used to investigate the implications of abnormal miR‐378 regulation on melanoma cell migration and invasion in vitro, and on tumorigenicity in vivo. Prediction and conformation of the miR‐378 target gene was undertaken using bioinformatic analysis and luciferase reporter system. Expression of miR‐378 was often increased in melanoma, and shown to potentiate its migration, invasion, and tumorigenicity. miR‐378 acted, at least partially, through inhibition of the potential target FOXN3 and via Wnt/β‐catenin pathway activation. The findings indicate that miR‐378 triggers melanoma development and progression. This miRNA could be a novel diagnostic and prognostic biological marker and provide utility for targeted treatment of melanoma.